Why is Oxygenta Pharma falling/rising?

As of 27-Oct, Oxygenta Pharmaceutical Ltd is experiencing a price increase, currently at Rs 62.38, reflecting a rise of 2.97 (5.0%). Despite this positive movement today, the stock has shown a decline of 10.89% over the past month and a significant drop of 28.68% year-to-date. Today's performance indicates that the stock has outperformed its sector by 5.12% and has gained 7% over the last two days. However, it opened with a loss of 3.8% and traded with a weighted average price closer to its intraday low of Rs 57.15. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 26.97% compared to the five-day average, which may indicate waning interest among investors.
Broader Market Context: In the context of the broader market, Oxygenta's short-term performance contrasts with the Sensex, which has gained 5.41% over the past month. While the stock has shown a positive movement today, its longer-term performance remains concerning, with a year-over-year decline of 41.43% compared to the Sensex's increase of 6.77%. This disparity highlights the challenges Oxygenta faces in regaining investor confidence amidst a generally positive market environment.